Whitepapers · April 2026 · 10 min read

Healthcare Beyond the Metros: The Tier-2 Diagnostics Opportunity

Under-penetrated Tier-2 and Tier-3 cities are driving the next wave of growth in organised diagnostics.

Demand drivers

Rising insurance coverage, chronic disease prevalence and preventive health awareness are expanding demand outside the metros.

Hub-and-spoke networks with strong local brand recall and doctor relationships are outperforming national chains in many regions.

This article is for information only and does not constitute investment advice or an offer to invest.

Formalisation, supply-chain diversification and deepening capital markets are creating a generation of institutional-grade SMEs.

How precision engineering and specialty chemical SMEs are winning global supply contracts — and what it takes to scale.

SME IPO activity remains robust, but we believe valuation discipline matters more than ever.